Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market, Single Blind, Multicenter, Randomized, Controlled Trial of HYMOVIS® Intra-articular Injections in Active Subjects With Knee Osteoarthritis

NCT03281837 is registered in ClinicalTrials.gov with Fidia Pharma USA Inc. as lead sponsor.

NCT NCT03281837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03281837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market, Single Blind, Multicenter, Randomized, Controlled Trial of HYMOVIS® Intra-articular Injections in Active Subjects With Knee Osteoarthritis
Lead sponsor
Fidia Pharma USA Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2017
Completion date
July 16, 2020
Enrollment
148 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis, osteoarthritis, knee, patellofemoral osteoarthritis